Medical therapy for myopia progression is an important part of managing myopia in children. One of the most commonly used treatments is low-dose atropine, which has been shown to reduce myopia progression in children by preventing the elongation of the eyeball. At Dr. Bhowal’s Myopia Clinic, our experts provide personalized treatment plans, closely monitoring the effects and adjusting the therapy as needed.
In addition to atropine, we offer other medical interventions that may be appropriate depending on the child’s age, myopia progression rate, and response to treatment. Medical therapy is typically used in combination with myopia control lenses or other treatments for maximum effectiveness. Our team ensures that each child receives the right combination of care for long-term vision health.
Medical therapy for myopia progression typically involves the use of low-dose atropine eye drops, which can reduce myopia progression by slowing the elongation of the eyeball.
Yes, low-dose atropine is safe for children when prescribed and monitored by an experienced eye care professional. It has been extensively studied and found to be effective in slowing myopia progression.
The duration of treatment with atropine drops varies depending on the child’s response and the progression of myopia. Typically, the drops are used nightly for several years or until myopia stabilizes.
Common side effects may include light sensitivity or mild difficulty with near vision, but these are generally temporary and resolve once the treatment is stopped or adjusted.
Yes, medical therapy can be combined with other treatments like myopia control lenses or orthokeratology for maximum effectiveness in slowing myopia progression.